Lori Lawley

Director of Finance/CFO at LUMOS PHARMA, INC.

42 year

Health Technology

Commercial Services

Consumer Services

Profile

Lori Lawley is currently Chief Financial Officer & Secretary at Lumos Pharma, Inc. since 2020.
Former positions include Vice President-Finance & Controller at NewLink Genetics Corp.
from 2018 to 2020 and Senior Manager at Ernst & Young LLP from 2014 to 2015.
Education includes undergraduate and graduate degrees from McCombs School of Business.

Lori Lawley active positions

Companies	Position	Start
LUMOS PHARMA, INC.	Director of Finance/CFO	03/07/2021

All active positions of Lori Lawley

Former positions of Lori Lawley

Companies	Position	End
LUMOS PHARMA, INC.	Comptroller/Controller/Auditor	29/02/2020
Ernst & Young LLP Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services	Corporate Officer/Principal	31/03/2015

See the detail of Lori Lawley's experience

Training of Lori Lawley

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Lori Lawley's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
Ernst & Young LLP Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services	Commercial Services
NewLink Genetics Corp. NewLink Genetics Corp. Pharmaceuticals: MajorHealth Technology Discovers, develops, and commercializes novel immunotherapeutic products for treatment of cancer	Health Technology
McCombs School of Business McCombs School of Business Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Lumos Pharma, Inc. Lumos Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops and markets therapeutics for rare diseases	Health Technology